SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001136261-20-000092
Filing Date
2020-03-17
Accepted
2020-03-17 17:20:51
Documents
64
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K body10k.htm 10-K 745470
2 DESCRIPTION OF SECURITIES OF SEELOS THERAPEUTICS, INC. exh4-25.htm EX-4.25 25289
3 AMENDMENT TO LICENSE AGREEMENT, DATED AS OF FEBRUARY 8, 2019, BY AND AMONG LIGAN exh10-30.htm EX-10.30 6684
4 CONSENT exh23-1.htm EX-23.1 2326
5 302 CERTIFICATE exh31-1.htm EX-31.1 7478
6 906 CERTIFICATE exh32-1.htm EX-32.1 2546
  Complete submission text file 0001136261-20-000092.txt   3667550

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT seel-20191231.xml EX-101.INS 452798
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT seel-20191231.xsd EX-101.SCH 58264
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT seel-20191231_cal.xml EX-101.CAL 73134
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT seel-20191231_def.xml EX-101.DEF 169588
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT seel-20191231_lab.xml EX-101.LAB 425071
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT seel-20191231_pre.xml EX-101.PRE 324237
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22245 | Film No.: 20722068
SIC: 2834 Pharmaceutical Preparations